BNP Paribas Financial Markets’s Guardant Health GH Stock Holding History

BNP Paribas Financial Markets’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$26.9M	Sell	179,490 -393,160	-69%	-$42.8M	0.01%	1097
2026 Q1	$52.9M	Sell	572,650 -52,126	-8%	-$5.23M	0.03%	656
2025 Q4	$63.8M	Buy	624,776 +567,008	+982%	+$50.7M	0.03%	571
2025 Q3	$3.61M	Sell	57,768 -81,183	-58%	-$4.42M	﹤0.01%	2195
2025 Q2	$7.23M	Sell	138,951 -311,520	-69%	-$13.9M	﹤0.01%	1641
2025 Q1	$19.2M	Buy	450,471 +9,145	+2%	+$395K	0.01%	1076
2024 Q4	$13.5M	Buy	441,326 +374,419	+560%	+$10.5M	0.01%	1201
2024 Q3	$1.53M	Sell	66,907 -149,327	-69%	-$4.23M	﹤0.01%	2207
2024 Q2	$6.24M	Buy	216,234 +112,883	+109%	+$2.63M	0.01%	1308
2024 Q1	$2.13M	Sell	103,351 -220,102	-68%	-$4.72M	﹤0.01%	2015
2023 Q4	$8.75M	Buy	323,453 +104,302	+48%	+$2.74M	0.01%	1093
2023 Q3	$6.5M	Buy	219,151 +19,562	+10%	+$688K	0.01%	1106
2023 Q2	$7.15M	Sell	199,589 -41,776	-17%	-$1.2M	0.01%	1057
2023 Q1	$5.66M	Buy	241,365 +172,452	+250%	+$4.93M	0.01%	1179
2022 Q4	$1.87M	Buy	+68,913	New	+$3.15M	﹤0.01%	1805
2022 Q3	–	Sell	-18,676	Closed	-$753K	–	4838
2022 Q2	$753K	Sell	18,676 -10,598	-36%	-$525K	﹤0.01%	2399
2022 Q1	$1.94M	Buy	29,274 +18,180	+164%	+$1.24M	﹤0.01%	1840
2021 Q4	$1.11M	Sell	11,094 -50,256	-82%	-$5.2M	﹤0.01%	2512
2021 Q3	$7.67M	Sell	61,350 -9,389	-13%	-$1.12M	0.01%	1068
2021 Q2	$8.79M	Buy	70,739 +35,097	+98%	+$4.72M	0.01%	1003
2021 Q1	$5.44M	Buy	35,642 +19,489	+121%	+$2.95M	0.01%	1126
2020 Q4	$2.08M	Buy	16,153 +13,790	+584%	+$1.59M	﹤0.01%	1616
2020 Q3	$264K	Sell	2,363 -6,115	-72%	-$559K	﹤0.01%	2600
2020 Q2	$688K	Sell	8,478 -2,487	-23%	-$200K	﹤0.01%	1959
2020 Q1	$763K	Buy	10,965 +910	+9%	+$69.8K	﹤0.01%	2110
2019 Q4	$786K	Buy	10,055 +7,491	+292%	+$540K	﹤0.01%	2176
2019 Q3	$164K	Sell	2,564 -332	-11%	-$29.2K	﹤0.01%	2853
2019 Q2	$250K	Buy	+2,896	New	+$221K	﹤0.01%	2470

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BNP Paribas Financial Markets's GH Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Guardant Health (GH) stake by 69% in Q2 2026, selling an estimated $42.8M and leaving 179,490 shares worth $26.9M. The position accounts for 0.01% of the portfolio, ranked #1097.

BNP Paribas Financial Markets first reported a position in GH in Q2 2019 and has held it in 28 quarters since. The position peaked at $63.8M in Q4 2025. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

BNP Paribas Financial Markets held 179,490 shares of Guardant Health worth $26.9M as of Q2 2026.
BNP Paribas Financial Markets sold 393,160 Guardant Health shares in Q2 2026, an estimated $42.8M.
Guardant Health made up 0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #1097 holding.
BNP Paribas Financial Markets first reported a position in Guardant Health in Q2 2019 and has held it in 28 quarters since.
BNP Paribas Financial Markets's Guardant Health position peaked at $63.8M in Q4 2025.
597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.